Posts Tagged ‘Blood’
Video: Embrace Life – Always wear your seatbelt
Monday, July 26th, 2010New way to harvest bone marrow for stem cell transplant
Saturday, July 18th, 2009Bone marrow is the seat of stem cells which give rise to the cells that circulate in blood. These cells are:
Red cells (erythrocyte) – carry oxygen
White cells (leukocyte) – fight infections
Platelets (thrombocyte) – help with blood clotting
Image source: Wikipedia
There are a number of diseases in which the bone marrow stem cells may die, be replaced by fibrous tissue or by cancer which then leads to decreased blood cells. This defect will then lead to fatigue, tiredness (due to decreased red cells), repeated infections (due to decreased white cells) and easy bleeding (due to decreased platelets).
The technique of harvesting stem cells from a donor bone marrow for transplant to a recipient whose marrow is not functioning is a life saving procedure. However, the technique for harvesting these cells is very old, painful and has a fair share of complications.
In this TED talk, Daniel Kraft demonstrates a new device which aims to make the whole process of bone marrow harvesting for stem cell transplant safer and simpler (Link to Video).
More information on Stem Cell Transplantation – Mayo Clinic
Methemoglobinemia
Sunday, March 8th, 2009(Double click on any word for definition)
Hemoglobin contains 4 heme groups and each heme group contains Fe2+
When Fe2+ gets oxidized to Fe3+ it is called MetHb
MetHb not only reduces the oxygen binding capacity of Hb but interferes with oxygen unloading to the tissues thereby shifting the oxygen dissociation curve to the left
Under physiologic conditions MetHb is continuously produced due to the oxidizing effect of oxygen but is reduced back to Hb by cytochrome b5 reductase (NADPH MetHb reductase)
Normal levels of MetHb in humans < 2%
5 g/dl of deoxyHb produces cyanosis
MetHb produces cyanosis at 1.5 g/dl
Most commonly caused by drugs:
|
Benzocaine |
Dapsone |
Primaquine |
|
Lidocaine |
Nitrates |
Sulfonamides |
|
Prilocaine |
Nitroprusside |
Phenazopyridine |
Pulse oximetry & Co-oximetry
Regular pulse oximeter measures UV absorption only 2 wavelengths for oxyHb (940nm) and deoxyHb (660)
Co-oximeter measures light absorption of blood at multiple UV wavelengths
They can measure the percentages of oxyHb, deoxyHb, carboxyHb and MetHb
Require a blood sample – cannot be used for continuous monitoring
Pulse oximeter is unreliable for measuring MetHb because methemoglobin is detected by both the oxyHb (940 nm) and deoxyHb (660 nm) sensors of the oximeters
At low levels (20%), methemoglobin is detected primarily by the deoxyHb sensor,and a pulse oximeter may show a falsely low oxygen saturation
At high methemoglobin levels (70%), detection by the oxyhemoglobin sensor pre- dominates, and a pulse oximeter may show a falsely high reading
Methylene blue, the antidote for MetHb, is also detected by the pulse oximeter’s deoxyHb sensor, which leads to the potential for falsely low post-treatment oxygen saturation readings
Clinical findings
Cyanosis unresponsive to oxygen
Cyanosis in the presence of normal (calculated) oxygen saturation
Saturation gap = Calculated sat – pulse oxymetry
Suspect presence of abnormal Hb if the saturation gap > 5% (+ or -)
Saturation gap is not proportional to MetHb level
Treatment
Symptomatic and those with MetHb > 20% should receive methylene blue
Methylene blue acts as a cofactor for NADPH MetHb reductase thereby converting Fe3+ to Fe2+ in Hb
Methylene blue is not effective in patients with G6PD deficiency as they have very low levels of NADPH – will cause hemolysis
Side effects of methylene blue includes bluish skin which may complicate assessment of cyanosis
Methylene blue also causes MetHb (in higher doses) !!!!!
If not responding to methylene blue – ? sulfHb, ongoing toxicity esp if toxin is ingested or G6PD deficiency – you may also have to consider an alternative diagnosis !!!
Rarely hyperbaric oxygen and/or exchange transfusion may be done
Artificial Blood
Friday, August 29th, 2008Organs are next:
A study published early online in Blood showed for the first time how functional oxygen-carrying erythrocytes can be generated from human embryonic stem cells in large quantities. The technique seems to be an important first step towards producing an unlimited supply of disease-free blood.


